Multiple Sclerosis Antibodies Appear in Blood Long Before Symptoms Appear

A new study found that the antibodies found in the blood of people suffering from multiple sclerosis may appear much earlier than the onset of the disease and its symptoms.

"If our results can be replicated in larger populations, our findings may help to detect MS earlier in a subgroup of patients," said study author Viola Biberacher, MD, with Technical University in Munich, Germany. "Finding the disease before symptoms appear means we can better prepare to treat and possibly even prevent those symptoms. This finding also demonstrates that the antibody development to the KIR4.1 protein, a protein found in some people with MS, precedes the clinical onset of disease suggesting a role of the autoantibody in how the disease develops."

Multiple sclerosis - Symptoms - Causes - Diagnosis - Treatment
Multiple sclerosis can be a severely disabling autoimmune disease that affects the myelin or insulating layer of the nerve fibers and typically has remissions and relapses

For the study, 16 healthy blood donors who were later diagnosed with MS were compared to 16 healthy blood donors of the same age and sex who did not develop MS. Scientists looked for a specific antibody to KIR4.1. Samples were collected between two and nine months before the first symptoms of MS appeared.

Next, researchers looked at antibody levels in the blood at additional time points up to six years before and then after disease onset in those who had the KIR4.1 antibody in their blood.

All of the healthy controls tested negative for the KIR4.1 antibody. Of those who later developed MS, seven people tested positive for the antibodies, two showed borderline activity and seven were negative.

Multiple Sclerosis – Treatment to Reduce Symptoms and Modify course of Disease
Multiple sclerosis is treated with drugs that modify the course of the disease, suppress immunity and relieve symptoms.

In the study, KIR4.1 antibodies were found in the people with pre-clinical MS several years before the first clinical attack. Concentrations of the antibody varied at different time points during pre-MS in individual people.

"The next step is to confirm these findings in larger groups and determine how many years before onset of disease the antibody response develops," said Biberacher.

The study was supported by the German Ministry for Education and Research and the German Competence Network for Multiple Sclerosis.

The American Academy of Neurology, an association of more than 27,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer''s disease, stroke, migraine, multiple sclerosis, brain injury, Parkinson''s disease and epilepsy.

Source-Newswise